All stock lists
Comp En De Mn Cemig (New York Stock Exchange:CIG)
BR · Delayed Price · Currency is USD
Utilities · Regulated Electric
$1.84-$0.06 (-3.16%)
Market cap
$5.26B
Insider Score
Health Score
Analyst consensus
Listed since
Nov 18, 1996
Website
Insider Score
––Not scored
CIG Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From CIG’s reported statements · Q2 2026 (trailing 12 months)
Profitability15 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $43.65B
- Net income
- $4.60B
- Net margin
- 10.5%
Leverage8 / 20
A manageable debt load.
- Total debt
- $22.75B
- Cash
- $2.16B
- Net debt / EBITDA
- 2.30x
Liquidity9 / 20
Covers near-term obligations, without much room.
- Current assets
- $15.72B
- Current liabilities
- $13.46B
- Current ratio
- 1.17
Cash generation12 / 20
Roughly cash-neutral.
- Operating cash flow
- $5.20B
- Free cash flow
- $656.5M
- FCF margin
- 1.5%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 2863.7M
- Share growth (1y)
- 0.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CIG Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | $11.16 B | $10.46 B | $11.50 B | $10.53 B | $10.79 B | $9.71 B |
| Revenue Growth (YoY) | 3.43 % | 7.80 % | -6.52 % | 4.70 % | 21.78 % | 8.70 % |
| Cost of Revenue | $9.20 B | $9.23 B | $10.36 B | $9.02 B | $9.10 B | $8.00 B |
| Gross Profit | $1.95 B | $1.23 B | $1.14 B | $1.51 B | $1.69 B | $1.70 B |
| SG&A Expense | $52.78 M | $285.49 M | $307.36 M | $195.33 M | $180.70 M | $193.97 M |
| R&D Expense | $0.00 | $0.00 | $108.90 M | $0.00 | $10.81 M | $0.00 |
| Operating Expenses | $52.78 M | $285.49 M | $416.26 M | $484.69 M | $191.51 M | $346.93 M |
| Operating Income | $1.90 B | $942.30 M | $728.35 M | $1.02 B | $1.50 B | $1.36 B |
| Pretax Income | $1.03 B | $1.05 B | $2.23 B | $846.53 M | $1.38 B | $1.21 B |
| Tax Provision | $87.90 M | $69.95 M | $356.99 M | $49.79 M | $189.81 M | $175.03 M |
| Net Income | $945.03 M | $978.54 M | $1.88 B | $796.74 M | $1.19 B | $1.04 B |
| EPS (Basic) | $0.33 | $0.34 | $0.66 | $0.28 | $0.42 | $0.36 |
| EPS (Diluted) | $0.33 | $0.34 | $0.66 | $0.28 | $0.42 | $0.36 |
| Shares Outstanding | 2.86 B | 2.86 B | 2.86 B | 2.86 B | 2.86 B | 2.86 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.